Clinical Trial: CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07276711) titled 'CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material' on Dec. 01.

Brief Summary: The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.

Study Start Date: Feb., 2026

Study Type: INTERVENTIONAL

Condition: Aortic Valve Stenosis Aortic Stenosis Aortic Valve Disease

Intervention: DEVICE: EmStop Embolic Protection System

EmStop Embolic Protection System used during TAVR procedure

DEVICE: Boston Scientific Sentinel ...